Clinical Trial Update: A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of UNR844-Cl eye drops in presbyopia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• UNR844 Chloride (UNR844-Cl) Eye Drops (UNR844-Cl)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Presbyopia | Phase 2 | Status: COMPLETED | Results posted: 2020-11-27